Antisocial personality disorder is treatable, but no single therapy has earned the kind of clear, first-line endorsement that exists for conditions like depression or anxiety. The evidence base is thinner than you might expect for a disorder this well known, partly because people with ASPD are frequently excluded from research and clinical programs. Still, several psychotherapy approaches have shown real promise in reducing aggression and offending, behavioral interventions work surprisingly well for co-occurring substance use, and a handful of medications can help manage specific symptoms like impulsivity and irritability. The challenge lies less in the absence of options and more in the difficulty of getting people into treatment, keeping them there, and adapting standard approaches to a population that often views therapy with suspicion.
Mentalization-Based Treatment Has the Strongest Recent Evidence
The most encouraging clinical trial data for ASPD-specific psychotherapy comes from mentalization-based treatment, or MBT-ASPD. This approach focuses on helping people understand their own mental states and those of others, rather than targeting anger or violent behavior directly. It is delivered as group psychotherapy, using a semi-structured process in which participants develop personal formulations of their difficulties and practice learning from one another.1PubMed. Mentalizing and Group Psychotherapy: A Novel Treatment for Antisocial Personality Disorder
The largest trial to date, known as MOAM, enrolled men convicted of criminal offences on community probation in England and Wales. At twelve months, participants who received MBT-ASPD had significantly lower aggression scores than those receiving probation as usual, with a medium-to-large effect size. The treatment group’s average aggression score was roughly half that of the comparison group.2PubMed. Mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales (Mentalization for Offending Adult Males, MOAM): a multicentre, assessor-blinded, randomised controlled trial That is a meaningful result for a population where even small reductions in aggression translate into fewer victims and lower criminal justice costs.
The MOAM trial also produced favorable economic data. Over two years, the MBT group had lower total service costs and lower offence-related costs than the probation-as-usual group. Each unit reduction in aggression was associated with a cost saving of roughly £93, and the intervention group saved an estimated £2,000 overall, though that difference did not reach statistical significance.3PLOS One. Cost-effectiveness of a mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales Still, a treatment that reduces aggression and does not cost more is worth taking seriously, especially when alternatives are scarce.
Schema Therapy and Other Psychotherapy Approaches
Schema therapy takes a different route. It identifies deep-seated patterns, or “schemas,” that drive problematic behavior and works to replace them with healthier ways of relating to others and managing emotions. In a Dutch multicenter trial of forensic inpatients with personality disorders including ASPD and psychopathic traits, preliminary findings from the first thirty patients suggested that schema therapy was yielding better outcomes than treatment as usual in reducing recidivism risk and promoting community reintegration. Those results were not yet statistically significant at the preliminary stage and should be treated cautiously.4International Journal of Forensic Mental Health. Schema Therapy for Forensic Patients with Personality Disorders: Design and Preliminary Findings of a Multicenter Randomized Clinical Trial in the Netherlands But the fact that patients with psychopathic features responded at all challenges the long-held belief that this subgroup is untreatable.
A broader meta-analysis looking at treatment and recidivism in people diagnosed with ASPD found that controlled studies showed no statistically significant differences between treatment and treatment-as-usual groups, though the direction of the results favored treatment. Uncontrolled studies suggested people with ASPD benefited from treatment about as much as those without ASPD.5International Journal of Forensic Mental Health. Can Antisocial Personality Disorder Be Treated? A Meta-Analysis Examining the Effectiveness of Treatment in Reducing Recidivism for Individuals Diagnosed with ASPD The signal is weak, but it consistently points in the right direction, and the small number of available studies is a bigger problem than the findings themselves.
Contingency Management Works, Especially for Substance Use
One of the more counterintuitive findings in ASPD research is how well contingency management performs. Contingency management is straightforward: it provides tangible rewards for meeting specific behavioral goals, like submitting drug-free urine samples or attending counseling sessions. You might expect that people characterized by manipulativeness and poor compliance would game the system. Instead, the reward structure seems to work precisely because it offers immediate, concrete reinforcement, which aligns with how many people with ASPD process motivation.
In a study of cocaine-dependent patients, those with ASPD were actually more likely to abstain from cocaine during treatment than patients without ASPD, and this effect was driven primarily by the contingency management condition.6PubMed. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions A Cochrane review found that contingency management added to standard maintenance improved social functioning and counseling attendance for outpatients with ASPD, though findings on drug use itself were mixed across studies.7PubMed Central. Psychological interventions for antisocial personality disorder An updated version of that review found low-certainty evidence that combining contingency management with standard maintenance may improve family and social functioning at six months.8PubMed Central. Psychological interventions for antisocial personality disorder
The practical takeaway is that if you or someone you know has ASPD alongside a substance use problem, programs that incorporate reward-based incentives may be worth seeking out. The evidence for contingency management in this population is more solid than for most other interventions.
People with ASPD Can Benefit from Substance Abuse Programs
A persistent clinical myth holds that people with ASPD undermine substance abuse treatment and should be screened out. The research tells a more encouraging story. In a randomized trial comparing two therapeutic community programs of different lengths, clients with ASPD were just as likely to complete treatment as clients without ASPD and showed the same reductions in drug use and criminal recidivism.9PubMed. Therapeutic community treatment for substance abusers with antisocial personality disorder
Similar findings emerged in a study of marijuana-dependent young adults: despite entering treatment with more severe histories of arrests, assaults, and alcohol dependence, participants with ASPD showed no differences from non-ASPD participants in treatment retention or substance use outcomes at eight weeks or six months.10PubMed Central. Differences in treatment outcome among marijuana-dependent young adults with and without antisocial personality disorder In a methamphetamine treatment study of homeless men, those with ASPD actually provided more drug-free urine samples than those without ASPD, though they earned fewer vouchers for other prosocial behaviors.11PubMed Central. Antisocial personality disorder predicts methamphetamine treatment outcomes in homeless, substance-dependent men who have sex with men
The picture that emerges is nuanced. People with ASPD can achieve drug abstinence at rates comparable to or even better than peers without ASPD, but they often struggle more with broader prosocial behaviors like health-promoting activities and positive social engagement. Treatment programs that account for this gap, perhaps by using contingency management for substance targets while adding separate interventions for social functioning, may do better than one-size-fits-all approaches.
Medication Targets Symptoms, Not the Disorder Itself
No medication is approved specifically for ASPD, and none addresses the core personality features like chronic deceitfulness, disregard for others’ rights, or lack of remorse. What medication can do is manage specific symptoms that frequently accompany the disorder and create the most day-to-day risk: impulsivity, irritability, and aggression.
The atypical antipsychotic quetiapine has shown effectiveness in reducing impulsivity, hostility, aggressiveness, irritability, and rage reactions in patients with ASPD.12PubMed. Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine Other atypical antipsychotics and mood stabilizers are sometimes used off-label, drawing on evidence from related conditions like borderline personality disorder, but the evidence base for ASPD specifically remains limited.
Selective serotonin reuptake inhibitors may help with impulsive aggression, since serotonin plays a central role in regulating impulsive behavior. When someone with ASPD also has depression, an SSRI is considered a better choice than antidepressants that boost noradrenaline or dopamine, which could actually increase impulsivity and aggression.13Brazilian Journal of Psychiatry. Pharmacological treatment of impulsivity and aggressive behavior SSRIs have shown some effect on impulsivity and aggression in personality disorder patients, though effect sizes vary widely across studies and the results are inconsistent outside of specific comorbid conditions.14International Journal of Neuropsychopharmacology. Evidence-based pharmacotherapy for personality disorders
Medication is best understood as an adjunct, something that can lower the temperature enough for psychotherapy to get traction, rather than a standalone fix.
Why Keeping People in Treatment Is So Difficult
The single greatest obstacle to treating ASPD is not the lack of available therapies; it is keeping people engaged long enough for those therapies to work. People with ASPD frequently describe real barriers to forming a working relationship with therapists, including difficulty trusting authority figures, discomfort with vulnerability, and past negative experiences in institutional settings. Research on patient perspectives suggests that therapeutic alliance development is achievable but requires therapists to adapt their style, maintaining a non-judgmental and calm attitude while being firm and clear.15Taylor & Francis Online. Patients’ perspective on an optimal therapeutic alliance; facilitating engagement in treatment of antisocial personality disorder
From the therapist’s side, working with ASPD patients creates its own challenges. Clinicians report a range of intense reactions, from fear and frustration to, sometimes, unexpected feelings of vitality when the work goes well. Studies of therapist experience identify several keys to managing these dynamics: getting to know the patient well enough to feel safe, maintaining clear boundaries alongside an open-minded stance, and paying careful attention to timing when making interventions in what researchers describe as a “high-speed culture” of interaction.16PubMed Central. Antisocial personality disorder in group therapy, kindling pro-sociality and mentalizing Clinical teams treating this population need active support around countertransference and burnout, or the treatment program itself can break down regardless of how good the model is on paper.
Court-Mandated Treatment and the Dropout Problem
If people with ASPD tend to drop out of voluntary treatment, one obvious question is whether requiring them to attend works any better. The answer, somewhat uncomfortably, is yes. In a study comparing dropout rates among substance abuse patients with and without ASPD, those with ASPD who entered treatment voluntarily were significantly more likely to drop out than any other group, completing fewer days of treatment. But patients with ASPD whose treatment was court-mandated stayed in treatment at rates comparable to non-ASPD patients.17PubMed Central. The interactive effects of antisocial personality disorder and court-mandated status on substance abuse treatment dropout
This creates an ethical tension. On one hand, the evidence is clear that external pressure helps retention, and retention is necessary for any treatment to work. On the other hand, critics have pointed out that people with ASPD under legal pressure may use sophisticated strategies to give the appearance of progress without genuine internal change.18PubMed Central. Rehabilitating antisocial personalities: treatment through self-governance strategies Whether court-mandated attendance translates into real improvements in daily functioning and reduced reoffending, or merely into better performance within the treatment setting, is something clinicians continue to wrestle with. The MOAM trial’s positive results were achieved in a probation sample, which suggests that at least some externally motivated patients do experience genuine change.
Intervening Early in Youth at Risk
ASPD cannot be diagnosed before age eighteen, but its precursors are often visible in childhood and adolescence. A subgroup of antisocial youth with what are called callous-unemotional traits, characterized by limited empathy, shallow emotions, and indifference to punishment, are at especially high risk of developing ASPD. This is where early intervention research has focused, and the findings are cautiously encouraging.
A systematic review found that children with callous-unemotional traits do show reductions in both those traits and their antisocial behavior when treated, though they typically start treatment with worse functioning and may still end with higher levels of antisocial behavior than peers without those traits.19PubMed. Practitioner Review: Involving young people with callous unemotional traits in treatment–does it work? A systematic review Social-learning-based parent training has emerged as a particularly effective approach when delivered early in childhood, producing lasting improvements in callous-unemotional traits.20PubMed. Callous-unemotional traits and the treatment of conduct problems in childhood and adolescence: a comprehensive review
For adolescents already involved in the criminal justice system, multisystemic treatment has demonstrated long-term reductions in criminal activity, violent offenses, drug-related arrests, and incarceration in controlled studies with serious juvenile offenders.21PubMed. Multisystemic treatment of criminality and violence in adolescents This approach treats the young person within their broader environment, addressing family dynamics, school problems, and peer influences simultaneously rather than pulling the teenager into an office for individual therapy disconnected from their real life.
The research on callous-unemotional traits underscores that the earlier you intervene, the better the odds. Waiting until adulthood, when personality patterns have fully consolidated and the person has accumulated criminal convictions, legal involvement, and damaged relationships, makes every form of treatment harder.22PubMed. Developmental pathways to severe antisocial behavior: interventions for youth with callous-unemotional traits
Experimental Approaches Using Brain Stimulation and Neurofeedback
Several research groups are exploring whether directly modulating brain activity could complement psychological treatment for people with ASPD and related profiles. Transcranial direct current stimulation, which delivers a weak electrical current to targeted brain areas through scalp electrodes, is being tested as an intervention to increase empathy and reduce violent behavior in forensic populations.23PubMed Central. Transcranial direct current stimulation (tDCS) as an intervention to improve empathic abilities and reduce violent behavior in forensic offenders: study protocol for a randomized controlled trial Early findings from a high-definition version of this technique suggest it can reduce reactive aggression, both on laboratory tasks and self-report measures, after a week of sessions.24Erasmus University Rotterdam. Understanding the aggressive brain: High-definition transcranial direct current stimulation (HD-tDCS) in reducing aggression and as a treatment intervention in forensic patients
Neurofeedback, in which a person learns to modulate their own brain-wave patterns through real-time feedback, has also shown preliminary results. A pilot study with offenders scoring high on psychopathy found that EEG neurofeedback training shifted resting brain-wave patterns, reducing slow-wave activity and increasing alpha-band power, changes associated with improved self-regulation.25PLOS ONE. Balancing the brain of offenders with psychopathy? Resting state EEG and electrodermal activity after a pilot study of brain self-regulation training A single case study reported that neurofeedback may strengthen the prefrontal cortex’s capacity to regulate the fight-or-flight response, though the authors were appropriately careful about drawing broad conclusions from one person.26International Journal of Behavioral Consultation and Therapy. Neurofeedback, Affect Regulation and Attachment: A Case Study and Analysis of Anti-Social Personality
All of these neurostimulation and neurofeedback approaches remain experimental. None is ready for routine clinical use, and the studies are small. But they represent a genuinely different angle of attack, working on the biological substrates of empathy and impulse control rather than relying entirely on a patient’s willingness to engage in talk therapy. If the early results hold up in larger trials, these tools could eventually serve as adjuncts that make psychotherapy more effective by priming the brain for change.
Why So Little Treatment Infrastructure Exists
One of the most frustrating aspects of ASPD treatment is the gap between what research shows is possible and what most health systems actually provide. People with ASPD are routinely excluded from mental health services. Many clinicians view the condition as untreatable and decline to take these patients, which in turn means fewer people with ASPD enter studies, which perpetuates the evidence gap. Researchers have explicitly called for practice-focused treatment frameworks because the current lack of systematic guidance leaves clinicians without direction and leaves patients without access.27Taylor & Francis Online. Treatment of antisocial personality disorder: Development of a practice focused framework
The economic argument for investing in ASPD treatment is strong even when the clinical evidence is imperfect. The costs of untreated ASPD fall on the criminal justice system, emergency departments, social services, and the people harmed by violence and fraud. The MOAM cost-effectiveness data showed that MBT-ASPD was at worst cost-neutral and at best cost-saving compared to probation alone.28PLOS One. Cost-effectiveness of a mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales In a system where the default is no treatment, even modest improvements in aggression represent a real return on investment. The barrier is not cost; it is institutional willingness to serve a population that many providers would prefer to avoid.
Virtual Reality and AI-Driven Tools on the Horizon
Looking further ahead, some researchers are exploring technology-driven approaches that could sidestep some of the engagement problems inherent to traditional therapy. Virtual reality environments designed for perspective-taking exercises may improve empathy by placing the participant in scenarios that require recognizing and responding to others’ emotional states. AI-driven predictive tools are being developed to identify relapse risk and personalize treatment plans.29Lecture Notes in Education Psychology and Public Media. Emerging Therapies for Antisocial Personality Disorder: Psychotherapeutic and Technological Advances These tools target core deficits like emotional dysregulation and impaired social cognition, and they offer something that traditional psychotherapy does not: scalability and novelty. For a population that often finds conventional therapy alienating, the gamified quality of VR-based exercises could provide a less threatening entry point. That said, these technologies are at the proof-of-concept stage and have not yet been validated in rigorous trials with ASPD populations. Their promise is real but unproven.